| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 409,395 | 320,599 | 441,311 | 568,684 | | Cost of Revenue | 291,594 | 229,935 | 337,529 | 405,369 | | | Gross Profit | 117,801 | 90,664 | 103,782 | 163,315 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 116,162 | 97,483 | 108,054 | 130,348 | | Non Recurring | 7,830 | 15,564 | 143,476 | 6,204 | | Others | 3,340 | 3,260 | 3,196 | 3,269 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,531) | (25,643) | (150,944) | 23,494 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,952 | 5,936 | 5,243 | 4,790 | | Earnings Before Interest And Taxes | (6,579) | (19,707) | (145,701) | 28,284 | | Interest Expense | 6,371 | 5,430 | 6,672 | 8,026 | | Income Before Tax | (12,950) | (25,137) | (152,373) | 20,258 | | Income Tax Expense | (5,129) | (9,749) | (14,660) | 4,700 | | Minority Interest | (629) | (266) | (161) | 101 | | | | Net Income From Continuing Ops | (7,821) | (15,654) | (137,874) | 15,659 | | | Non-recurring Events | | Discontinued Operations | (1,367) | (17,340) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,817) | (32,994) | (137,874) | 15,659 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,817) | ($32,994) | ($137,874) | $15,659 |
|
0.31% Nasdaq 
0.05%
Income Statement
